buy hold sell

Buy, Hold, Sell: why this fund manager is hanging up on Vodafone

Royal London Sustainable Leaders, as the name suggests, focuses upon sustainable businesses. “Our investments are skewed towards companies with products and services that support transition to a cleaner, safer and more sustainable world,” says Mike Fox, who has managed the fund since 2003.

Fox says the fund’s stockpicking process is primarily bottom-up. However, alongside the usual fundamental analysis expected of any stockpicker, he also looks at the sustainability credentials of each company.

Buy, Hold, Sell: JPMorgan Claverhouse names its three picks

JPMorgan Claverhouse, in the UK equity income sector, has managed to increase its dividend for 46 years in a row. That is one of the longest periods on record for a pure UK equity trust, says the trust’s co-manager, Callum Abbot. It would be wrong, however, to think of Claverhouse as purely an income-focused trust. “We look for cheapness, quality and price momentum,” says Abbot.

Buy, Hold, Sell: a trio of ethical stock picks

Sarasin Responsible Global Equity is unusual in having a prescribed ‘buylist’ from which the manager can choose. The list of 120 equities is constructed by a team of 15 analysts at Sarasin & Partners, the fund’s managing company, headed by Jerry Thomas, co-manager of Sarasin Responsible Global Equity as well as a number of the company’s other funds.

Buy, Hold, Sell: three small-cap income shares

The fund is relatively new – roughly 18 months old – but our investment approach is a bit more established,” says Ken Wotton, co-manager of LF Gresham House UK Multi Cap Income. Over the past decade and more, Wotton has gained a reputation as a skilful stockpicker in the UK equities market. As well as managing the UK Multi Cap Income fund, he has run the LF Gresham House UK Micro Cap fund since 2009. Both funds have been renamed since Gresham House’s acquisition of the funds from Livingbridge in November 2018.

Buy, Hold, Sell: the healthcare trends to invest in

Across the world, the average human lifespan is increasing. However, while this is clearly good news, there are some downsides to the trend: primarily, as people live longer, their healthcare costs increase. The pressure is already being felt by governments in Europe, where healthcare spending is soaring. A similar trend is starting to be felt in rapidly developing Asian countries.

Buy, Hold, Sell: Aberdeen New Dawn investment trust

Over the past decade, there has been a steady growth in interest in Asia Pacific-focused funds and trusts among retail investors. Aberdeen New Dawn, however, has been offering investors a route into the region for almost 30 years.

‘New Dawn has been running since the 1980s and had a presence in Asia since the early 1990s,’ says co-manager James Thom, who has been part of the team for the past eight years. ‘We have a well-resourced team on the ground in Asia – one of the better-resourced teams in the sector.’

Buy, Hold, Sell: 'We have a very strong value perspective'

Every day it seems a mainstream fund announces a degree of environmental, social and governance (ESG) integration into its investment strategy,’ says David Osfield, manager of the EdenTree Amity International fund.

Amity, however, has had an ESG approach since its launch in 1999. Osfield adds: ‘This gives us a depth of experience, longevity and understanding. It is where the credibility comes from.’

Murray Income investment trust: seeking strong and stable dividend payments

As the name suggests, Murray Income trust focuses on dividend paying companies, aiming to provide shareholders with strong, reliable income growth; it prides itself on the fact that it has a 44-year track record of dividend growth. The current yield is around 5.1 per cent. The trust attempts to provide income primarily through investing in UK-listed shares, although it is able to hold up to 20 per cent of its portfolio outside of the UK.